ReGenMed and the University of Helsinki Collaborate Their Expertise on NAD+ Human Clinical Study
- Written by Newsfile
NAD+, a coenzyme referred to as "The Fountain of Youth Molecule", in a first-of-a-kind clinical study with top European university.
Bangkok, Thailand--(Newsfile Corp. - May 18, 2022) - ReGenMed is pleased to announce results of their exciting collaboration and clinical study with the University of Helsinki focused on their recent FDA-approved,...